Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-06-14
2011-06-14
Marschel, Ardin (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07960370
ABSTRACT:
A pharmaceutical formulation comprising at least one omega-3 polyunsaturated fatty acid in free acid form or a pharmacologically acceptable derivative thereof is contained in a soft gelatin capsule characterized in that the capsule comprises gelatin extracted by an extraction process comprising acid pre-treatment of a collagen source. One advantage of the present invention over a soft gelatin capsule containing the same formulation but comprising gelatin extracted by an extraction process comprising alkali pre-treatment of the collagen source is that the present invention does not harden significantly over time and thus has a longer shelf life.
REFERENCES:
patent: 4935243 (1990-06-01), Borkan et al.
patent: 5502077 (1996-03-01), Breivik et al.
patent: 6234464 (2001-05-01), Krumbholz et al.
patent: 6555316 (2003-04-01), Cohen et al.
patent: 2003/0064074 (2003-04-01), Chang et al.
patent: 2003/0161872 (2003-08-01), Chen et al.
patent: 2005/0089571 (2005-04-01), Beckert et al.
patent: 0 100 052 (1984-02-01), None
patent: 0225189 (1987-06-01), None
patent: 0 289 204 (1988-11-01), None
patent: 0289204 (1988-11-01), None
patent: 1310249 (2003-05-01), None
patent: 2 223 943 (1990-04-01), None
patent: 59-039834 (1984-03-01), None
patent: 62-195324 (1987-08-01), None
patent: 64-013021 (1989-01-01), None
patent: 64-038019 (1989-02-01), None
patent: 11-106333 (1999-04-01), None
patent: 2003510348 (2003-03-01), None
patent: 2003-146874 (2003-05-01), None
patent: 2001024780 (2001-04-01), None
patent: 2003080032 (2003-10-01), None
patent: WO 03/086104 (2003-10-01), None
patent: WO 2004/091317 (2004-10-01), None
Goldman, Lee, et al., Cecil Textbook of Medicine, Chapter 198, pp. 1060-1074 W.B.Saunders Company (2000).
Belluzzi, A., M.D., et al., “Effect of an Enteric-Coated Fish-Oil Preparation on Relapses in Crohn's Disease”, The New England Journal of Medicine, vol. 334, No. 24. Jun. 13, 1996, p. 1557-1560, XP-002111589.
English translation of an Office action dated Jan. 6, 2011 in JP application No. 2006-55677.
Communication of a notice of opposition for European Patent No. EP1755565, dated Dec. 6, 2010.
Opposition to European Patent No. EP1755565 by Catalent Pharma Solutions, Inc., dated Nov. 17, 2010.
Affidavit of Dennis Rowe, with Exhibits 1-9, from Opposition to European Patent no. EP1755565 by Catalent Pharma Solutions, Inc. (Date unavailable).
Opposition to European Patent No. EP1755565 by SPA Societa' Prodotti Antibiotici S.p.A., dated Nov. 17, 2010.
Opposition to European Patent No. EP1755565 by Pronova BioPharma Norge AS, dated Nov. 17, 2010.
Document D1 from Opposition to European Patent No. EP1755565 by Pronova BioPharma Norge AS, “Omega-3-acid ethyl esters (European Pharmacopoeia 2001).”.
Document D2 from Opposition to European Patent No. EP1755565 by Pronova BioPharma Norge AS, “Omega-3-acid triglycerides (European Pharmacopoeia 2001).”.
Document D3 from Opposition to European Patent No. EP1755565 by Pronova BioPharma Norge AS, “Product/Package Information for 'Seacor.” (Date unavailable)
Document D4 fromOpposition to European Patent No. EP1755565 by Pronova BioPharma Norge AS, “Quality Report of Batch 05502 KL.” (Date unavailable).
Document D5 from Opposition to European Patent No. EP1755565 by Pronova BioPharma Norge AS, “Information Gelatin.” (Date unavailable)
Document D10 from Opposition to European Patent No. EP1755565 by Pronova BioPharma Norge AS, “G. Reich, Formulation and physical properties of soft capsules from 'Pharmaceutical Capsules' by Podreck and Brian Jones, Chap. 11, Pharmaceuticals Press 2004.”
Bufton Roly
Buser Thomas
Sachetto Jean-Pierre
Hughes Alicia R
Marschel Ardin
LandOfFree
Type A gelatin capsule containing PUFA in free acid form does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Type A gelatin capsule containing PUFA in free acid form, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Type A gelatin capsule containing PUFA in free acid form will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2665270